Ambac Earnings Call Highlights Surging MGA Momentum

Ambac Financial Group ((OSG)) has held its Q1 earnings call. Read on for the main highlights of the call.

Ambac Financial Group’s latest earnings call struck a distinctly upbeat tone, highlighting strong operational momentum and sharp gains in non‑GAAP profitability despite lingering GAAP losses. Management emphasized surging revenues in Insurance Distribution, improving margins, better underlying loss ratios at Everspan, and visible benefits from cost cuts and technology investments, while carefully parsing out several one‑time headwinds.

Insurance Distribution Revenue Surge

Insurance Distribution was the growth engine, with total segment revenues jumping 92% year over year to $78.5 million in Q1 2026. The surge was powered by 42% organic growth and the October 2025 acquisition of ArmadaCare, which itself posted roughly 10% organic revenue growth versus its prior‑year quarter.

Insurance Distribution Profitability Expansion

Profitability in Insurance Distribution expanded even faster than revenue, underscoring operating leverage in the model. Adjusted EBITDA nearly quadrupled to about $25 million, lifting segment margins to roughly 32% from 17% a year ago and positioning the business as the primary driver of the group’s earnings improvement.

Material Improvement in Consolidated Non-GAAP Earnings

On a consolidated basis, Ambac showed a dramatic turnaround in non‑GAAP metrics, signaling healthier underlying earnings power. Adjusted EBITDA to shareholders rose to $20.1 million from a negative $1.3 million a year earlier, while adjusted net income improved to $16.6 million, or $0.37 per share, from a $6.0 million loss.

Narrowing of GAAP Net Loss

While still in the red on a GAAP basis, Ambac significantly narrowed its reported net loss to shareholders in the quarter. The GAAP loss improved to $6.9 million, or $0.13 per share, from $16.1 million, or $0.57 per share, reflecting stronger operations offset by one‑time legal and restructuring charges.

Everspan Premium Growth and Loss-Ratio Improvement

Everspan continued its repositioning with solid top‑line expansion and better underlying risk performance. Gross premiums written grew 19% to $104 million, net premiums written climbed 80% to $32 million, earned premiums rose 28% to $20 million, and the accident year loss ratio improved to 54%, with active programs around 57%.

Corporate Expense Reduction Progress

Cost discipline is becoming a tangible contributor to earnings as corporate overhead continues to fall. Reported corporate expenses were cut to just over $12 million from $15 million year over year, while adjusted corporate expenses dropped to $7.2 million from $10.6 million, reflecting ongoing restructuring and efficiency initiatives.

Balance Sheet Capacity and Financing

Ambac is leaning on its balance sheet to support growth while keeping leverage within defined bounds. Insurance Distribution’s pro forma net debt‑to‑EBITDA stood at about 3.2x, backed by five‑year bank facilities priced at an initial spread of 275 basis points over SOFR and expanded third‑party capacity that has grown from $1.5 billion to more than $2 billion.

Strategic M&A and Capital Deployment

The company continued to deploy capital into targeted M&A and minority stakes that deepen its MGA ecosystem. Ambac completed additional buy‑ins, acquiring another 10% of Octave Ventures and stakes in four other MGAs for roughly $44 million funded via cash and term loan expansion, while ArmadaCare delivered incremental value with continued organic growth.

Platform and AI Strategy

Management reiterated a clear technology roadmap aimed at building a scalable, data‑rich MGA platform. The firm is executing a two‑track AI strategy using both proprietary tools and curated partners, has selected Anthropic as a core AI solution, and is consolidating MGAs onto a unified tech stack to accelerate analytics and AI‑driven underwriting.

Strong Q1 Seasonality and Positive Outlook

Ambac framed Q1 as a seasonally strong quarter that outperformed initial plans, particularly in Accident and Health. Management kept full‑year guidance essentially unchanged for now but pointed to ongoing momentum, while noting that 1–2 carefully chosen de novo MGA launches are expected in 2026 as they prioritize disciplined growth.

Reported GAAP Loss and Everspan Pre-Tax Headwinds

Despite more robust non‑GAAP results, headline GAAP numbers still reflect the drag from legacy and restructuring items. The company posted a GAAP net loss of $6.9 million, and Everspan recorded an $8 million pre‑tax loss for the quarter, underscoring that the carrier platform remains in investment mode even as its accident year trends improve.

Large One-Time Litigation and Settlement Impact

One‑off legal events weighed heavily on reported results, particularly in the insurance carrier segment. A settlement related to a potential insurance claim added $2.1 million of losses and $5.8 million of legal expenses, contributing nearly 40 loss‑ratio points and inflating the reported net loss LAE ratio to 98.4% for the quarter.

Distorted Combined and LAE Ratios

Management cautioned that headline combined and LAE ratios were not reflective of normalized performance due to litigation, severance, and other timing effects. On a pro forma basis, they pointed to a combined ratio around 95%, which they said better matches long‑term expectations and supports the view that core underwriting is on a healthier footing.

De Novo MGA Cost Drag and Early-Stage Losses

Early‑stage investments in new MGAs remain a deliberate drag on earnings as Ambac builds out its platform. Roughly 40% of its MGAs were launched in 2024–2025, and these de novos reduced EBITDA by about $1.1 million in Q1 2026 compared with $0.6 million a year earlier, reflecting upfront costs before scale benefits materialize.

Non-Recurring and Compensation Charges

Reported results also carried several non‑recurring and compensation‑related items that management excludes from adjusted metrics. The quarter included about $1.1 million of acquisition and integration costs, $0.5 million of severance and restructuring, and $3.1 million of equity compensation, including a sizable catch‑up accrual that amplified GAAP expense.

Everspan LAE Volatility

Everspan’s loss adjustment expenses remained volatile, highlighting exposure in certain lines and the noise from legal activity. Although the accident year loss ratio improved, the reported net loss LAE ratio reached 98.4% due to legal and settlement charges, reminding investors that near‑term volatility can obscure the improving underlying trends.

Leverage and Collateral Considerations

Ambac’s use of leverage is meaningful but framed as manageable within its growth strategy and risk appetite. To support bank‑funded insurance financing, the company expanded facilities and provided equity in Everspan’s intermediate holding company as additional collateral, balancing growth ambitions with lender requirements and capital structure discipline.

Quarter-to-Quarter Variability and Seasonality

Management emphasized that investors should expect uneven quarterly results driven by inherent seasonality and the timing of new launches. Accident and Health tends to make Q1 the strongest quarter and Q4 the second‑strongest, while de novo MGA investments and program changes can add noise even as longer‑term trends point to improving profitability.

Forward-Looking Guidance and Outlook

Looking ahead, Ambac kept its 2026 guidance broadly intact despite Q1 topping internal expectations, signaling confidence tempered by prudence. Management expects organic growth to remain the primary driver, Accident and Health to account for about 30% of production, 1–2 new MGA startups in 2026, and no additional non‑controlling interest buy‑ins after the roughly $44 million deployed this quarter.

Ambac’s earnings call painted the picture of a company in transition that is beginning to show the financial benefits of its MGA platform and technology strategy. While GAAP losses, legal noise, and de novo costs still cloud the headline numbers, strong revenue growth, expanding margins, improving loss ratios, and disciplined capital deployment suggest a constructive setup for investors watching the story unfold.